Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Mark A Mandelkern
Affiliation
University of California at Irvine
ORCID
Career Start Year
1986
Papers
172
H Index
56
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37004462
Decomposing risky decision-making in methamphetamine use disorder: Behavioral updating and D2 dopamine receptors.
Drug Alcohol Depend
2023
36249526
The Effects of Citalopram and Thalamic Dopamine D<sub>2/3</sub> Receptor Availability on Decision-Making and Loss Aversion in Alcohol Dependence.
Psychiatry J
2022
33420479
Striatal dopamine D<sub>2</sub>-type receptor availability and peripheral 17β-estradiol.
Mol Psychiatry
2021
33927783
Information Transfer and Multifractal Analysis of EEG in Mild Blast-Induced TBI.
Comput Math Methods Med
2021
33783690
Casting a Wider NET: Is It Crohn's or Is It Neuroendocrine Tumor?
Dig Dis Sci
2021
33426968
The relationship between duration of abstinence and gray-matter brain structure in chronic methamphetamine users.
Am J Drug Alcohol Abuse
2021
32570138
No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users.
Drug Alcohol Depend
2020
32307299
EEG multifractal analysis correlates with cognitive testing scores and clinical staging in mild cognitive impairment.
J Clin Neurosci
2020
30753467
Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability.
Int J Neuropsychopharmacol
2019
28894300
Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Mol Psychiatry
2018
30343364
Effect of overnight smoking abstinence on a marker for microglial activation: a [<sup>11</sup>C]DAA1106 positron emission tomography study.
Psychopharmacology (Berl)
2018
29422498
Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [<sup>11</sup>C]DAA1106 Positron Emission Tomography Study.
Neuropsychopharmacology
2018
28664927
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Neuropsychopharmacology
2018
27876444
The functional neuroanatomy of verbal memory in Alzheimer's disease: [<sup>18</sup>F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory.
J Clin Exp Neuropsychol
2017
30766304
Neuromodulation for Treatment-Refractory PTSD.
Fed Pract
2017
28162919
Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
Am J Geriatr Psychiatry
2017
28215899
<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity Associated with Distinct Agitation Behaviors in Alzheimer Disease.
Am J Geriatr Psychiatry
2017
28262740
Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [<sup>11</sup>C]DAA1106 Positron Emission Tomography Study.
Neuropsychopharmacology
2017
29055679
Cerebral metabolic correlates of attention networks in Alzheimer's Disease: A study of the Stroop.
Neuropsychologia
2017
26880595
Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
Drug Alcohol Depend
2016
26657175
Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
Int J Neuropsychopharmacol
2016
26503310
Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
Neuropsychopharmacology
2016
26475671
Deep Brain Stimulation of the Basolateral Amygdala for Treatment-Refractory Posttraumatic Stress Disorder.
Biol Psychiatry
2016
27592844
Heterogeneity of anatomic regions by MR volumetry in juvenile myoclonic epilepsy.
Acta Neurol Scand
2016
27634830
Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence.
Int J Neuropsychopharmacol
2016
27329684
Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.
Neuropsychopharmacology
2016
27517963
Deep Brain Stimulation of the Basolateral Amygdala: Targeting Technique and Electrodiagnostic Findings.
Brain Sci
2016
27370018
Nicotinic acetylcholine receptor availability in cigarette smokers: effect of heavy caffeine or marijuana use.
Psychopharmacology (Berl)
2016
26830141
Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
Mol Psychiatry
2016
23966584
Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity.
Cereb Cortex
2015
26657223
Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
PLoS One
2015
26759785
Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.
Neuroimage Clin
2015
26696860
Discrete Scale Invariance of Human Large EEG Voltage Deflections is More Prominent in Waking than Sleep Stage 2.
Front Hum Neurosci
2015
25896164
Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
Mol Psychiatry
2015
25878272
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.
J Neurosci
2015
25993553
Midbrain dopamine D2/D3 receptor availability and drug craving are associated with mesocorticolimbic gray matter volume in methamphetamine users.
Mol Psychiatry
2015
25603861
Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
Int J Neuropsychopharmacol
2015
24021220
Neurobiology of delusions, memory, and insight in Alzheimer disease.
Am J Geriatr Psychiatry
2014
25551240
A naturalistic study of the association between antidepressant treatment and outcome of smoking cessation treatment.
J Clin Psychiatry
2014
25208824
Deep brain stimulation of the basolateral amygdala for treatment-refractory combat post-traumatic stress disorder (PTSD): study protocol for a pilot randomized controlled trial with blinded, staggered onset of stimulation.
Trials
2014
25156039
Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
Nucl Med Biol
2014
24850280
Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.
JAMA Psychiatry
2014
24873791
Subclinical seizures as a pitfall in 18F-FDG PET imaging of temporal lobe epilepsy.
Clin Nucl Med
2014
23184607
Functionalized magnetonanoparticles in visualization of intracranial tumors on MRI.
Mol Imaging Biol
2013
24447617
The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region.
Mol Imaging
2013
24148908
A positive relationship between harm avoidance and brain nicotinic acetylcholine receptor availability.
Psychiatry Res
2013
23844189
Multifractal detrended fluctuation analysis of human EEG: preliminary investigation and comparison with the wavelet transform modulus maxima technique.
PLoS One
2013
23387510
Association between cerebral metabolism and Rey-Osterrieth Complex Figure Test performance in Alzheimer's disease.
J Clin Exp Neuropsychol
2013
23429692
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.
Neuropsychopharmacology
2013
23582152
Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain.
Pain
2013
1 - 50 of 172
Column Actions
Search
Recommended Authors
Hang-Keun Kim
Biomedical Engineering Research Center, Gachon University
Career Start Year
2007
Number of shared co-authors
0
Young-Don Son
Gachon University
Career Start Year
2003
Number of shared co-authors
0
Carl Becker
University of Pittsburgh School of Medicine
Career Start Year
2003
Number of shared co-authors
0
Kyle B Womack
Washington University School of Medicine
Career Start Year
2000
Number of shared co-authors
5
Mark Vangel
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
Career Start Year
1999
Number of shared co-authors
0
In Kyoon Lyoo
Graduate School of Pharmaceutical Sciences, Ewha Womans University
Career Start Year
1995
Number of shared co-authors
0
Edson Amaro
Hospital Israelita Albert Einstein - Sao Paulo
Career Start Year
1994
Number of shared co-authors
1
Andrew Simmons
Institute of Psychiatry, King's College London
Career Start Year
1994
Number of shared co-authors
2
Kewei Chen
Beijing Normal University
Career Start Year
1993
Number of shared co-authors
5
Ramin V Parsey
Neuroscience Institute, Renaissance School of Medicine, Stony Brook University
Career Start Year
1991
Number of shared co-authors
2
Gary F Egan
Monash University
Career Start Year
1991
Number of shared co-authors
1
Julie C Price
Massachusetts General Hospital
Career Start Year
1991
Number of shared co-authors
2
Christopher H van Dyck
Yale University School of Medicine
Career Start Year
1990
Number of shared co-authors
6
Carolyn C Meltzer
Keck School of Medicine of University of Southern California
Career Start Year
1990
Number of shared co-authors
2
Pudugramam Murali Doraiswamy
Duke University School of Medicine
Career Start Year
1990
Number of shared co-authors
5
Thomas Ernst
University of Maryland School of Medicine
Career Start Year
1989
Number of shared co-authors
5
Egill Rostrup
University of Copenhagen
Career Start Year
1988
Number of shared co-authors
0
Andrew J Saykin
Indiana University School of Medicine
Career Start Year
1986
Number of shared co-authors
7
Eric M Reiman
Banner Alzheimer's Institute
Career Start Year
1984
Number of shared co-authors
6
Perry F Renshaw
University of Utah
Career Start Year
1983
Number of shared co-authors
1
Michael W Weiner
University of California San Francisco
Career Start Year
1983
Number of shared co-authors
7
Robert A Koeppe
University of Michigan ann arbor
Career Start Year
1981
Number of shared co-authors
5
Chester A Mathis
University of Pittsburgh
Career Start Year
1981
Number of shared co-authors
1
Richard E Carson
Yale University
Career Start Year
1981
Number of shared co-authors
6
Mark A Mintun
Mallinckrodt Institute of Radiology , Washington University School of Medicine
Career Start Year
1980
Number of shared co-authors
5
Helen S Mayberg
Icahn School of Medicine at Mount Sinai
Career Start Year
1980
Number of shared co-authors
4
Robert B Innis
National Institute of Mental Health
Career Start Year
1978
Number of shared co-authors
3
Michael D Devous
University of Texas Southwestern Medical Center
Career Start Year
1977
Number of shared co-authors
5
Godfrey D Pearlson
Yale School of Medicine, Yale University
Career Start Year
1977
Number of shared co-authors
9
Nathaniel M Alpert
Gordon Center for Medical Imaging, Massachusetts General Hospital
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Edythe D London
Brain Research Institute, University of California at Los Angeles
Co-authored papers
59
Arthur L Brody
VA San Diego Healthcare System
Co-authored papers
37
Steven M Berman
University of California los angeles
Co-authored papers
23
John R Monterosso
Dana and David Dornsife College of Letters, University of Southern California
Co-authored papers
8
Walter Ling
University of California Los Angeles
Co-authored papers
5
Bradley Voytek
Alfred P. Sloan Foundation, National Academy of Sciences, University of California Berkeley, University of California San Diego, University of California, San Diego
Co-authored papers
5
Richard A Rawson
David Geffen School of Medicine, University of California los angeles
Co-authored papers
4
Jennifer Bramen
Pacific Neuroscience Institute and Foundation
Co-authored papers
3
Sara L Simon
university of california los angeles Integrated Substance Abuse Programs
Co-authored papers
3
Karen Miotto
University of California at Los Angeles
Co-authored papers
3
Daniel H S Silverman
University of California los angeles
Co-authored papers
3
Magnus Dahlbom
David Geffen School of Medicine, university of california los angeles
Co-authored papers
2
Steven Shoptaw
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
2
Noriko Salamon
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
2
Linda Chang
University of Maryland School of Medicine
Co-authored papers
2
George Bartzokis
The David Geffen School of Medicine at the University of California Los Angeles
Co-authored papers
2
Florian Schlagenhauf
Max-Planck Institute for Human Cognitive and Brain Sciences
Co-authored papers
2
John C Mazziotta
University of California los angeles
Co-authored papers
2
Ruth O'Hara
Stanford University School of Medicine
Co-authored papers
2
Michael Bauer
Carl Gustav Carus University Hospital, Technische Universitat Dresden
Co-authored papers
2
Natalie Rasgon
Center for Neuroscience in Women's Health, Stanford University
Co-authored papers
2
Roger P Woods
University of California Los Angeles
Co-authored papers
2
B D Hassid
Co-authored papers
2
Russell A Poldrack
Stanford University
Co-authored papers
2
Peter C Whybrow
University of California, Linacre College, University of Oxford
Co-authored papers
2
Mark A Frye
The Mayo Clinic
Co-authored papers
1
Jennifer A Geaga
Co-authored papers
1
Paul M Thompson
University of Southern California
Co-authored papers
1
Gad A Marshall
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
1
Angelo Nacca
Istituto di Ricerche Farmacologiche Mario Negri
Co-authored papers
1
1 - 30